TABLE 5.
8 Months Post-A–CT |
24 Months Post-A–CT |
|||||||
---|---|---|---|---|---|---|---|---|
Predictor | β | SE | χ2(1) | r | β | SE | χ2(1) | r |
At-best ratings of AFF and AUT | ||||||||
C–CT | -1.6035 | 0.6135 | 6.83* | .29 | -0.7057 | 0.3659 | 3.72 | .21 |
AFF | -0.0067 | 0.0032 | 4.50* | .23 | -0.0058 | 0.0023 | 6.14* | .27 |
AUT | 0.0203 | 0.0082 | 6.16* | .27 | 0.0128 | 0.0059 | 4.81* | .24 |
At-worst ratings of AFF and AUT | ||||||||
C–CT | -1.2625 | 0.5919 | 4.55* | .24 | -0.5792 | 0.3636 | 2.54 | .18 |
AFF | -0.0115 | 0.0054 | 4.53* | .24 | -0.0088 | 0.0033 | 7.16* | .30 |
AUT | 0.0047 | 0.0058 | 0.66 | .09 | 0.0067 | 0.0046 | 2.14 | .16 |
Note. n = 81 for models with at-worst variables including 15 and 33 with relapse/recurrence events within 8 and 24 months, respectively; n = 83 for models with at-best variables including 16 and 33 with relapse/recurrence events within 8 and 24 months, respectively. C–CT coded as 1=8 months of continuation phase cognitive therapy, 0 = 8 months of assessment-only control. Negative and positive betas, respectively, mark longer and shorter estimated time-to-relapse/recurrence of major depressive disorder. Effect size r values ≥ .10, .30, and .50 mark small, medium, and large effects, respectively (Cohen, 1988). A–CT = acute phase cognitive therapy; AFF = affiliation; AUT = autonomy; C–CT = continuation phase cognitive therapy.
p < .05.